CCM is visiting the FIC
2018 in Shanghai. Before going to the exhibition and meeting China’s top
players in the food industry, we are updating you on China’s food ingredients
industry in this article, to let you go prepared for the event.
The
Food Ingredients China 2018 (FIC 2018), held from March 22-24 in Shanghai, is
an international brand show in the food additives industry with a huge
influence on the development of the food ingredients and additives market in
China. Highlights of this exhibition are natural and healthy foods as well as
machinery. According to the organizers, more than 90% of the exhibitors are
manufacturers, counting over 1,400 booths on 110,000 square meters space.
The
event displays commodities like antioxidants, bulking agents, egg products,
natural and organic food and additives, oils and fats, food processing
equipment, food testing equipment, vegetable protein, frozen and chilled food,
packaging machinery and materials, and honey as well as honey extracts,
Some
of China’s manufacturers, which you can visit at the exhibition for critical
relationship building, are:
Tianjin
Kangqi
Star
Lake Bioscience
Jiangxi
Tianxin
Guilin
Layn
Guangji
Pharmaceutical
Fufeng
Northeast
Pharmaceutical
Real
Nutriceutical
Guilin
Layn
The
FIC is the main platform to build sustainable relationships with China’s
players in the food ingredients industry, just like vitamins, amino acids,
starch, sweeteners and more. Hence, knowledge about the industry in China can
be the critical factor in making the best out of visiting the exhibition.
CCM
helps you to prepare for the FIC 2017 with news about some of China’s most
important food ingredients players.
Tianjin Kanqi lists
on New Third Board
In
January 2018, Tianjin Kangqi, a glycyrrhiza polysaccharide (GPS) producer with
USD31.72 million and covering a total area of 1.7 ha in the Tianjin
Economic-Technological Development Area, was listed on the National Equities
Exchange and Quotations (NEEQ, known as the New Third Board).
Tianjin
Kangqi has achieved significant progress in the R&D innovation and
practical application of GPS. Its GPS-containing Kangqi Capsule was put on the
market in December 2001 and proved to be effective in reducing symptoms of lung
diseases, such as cough and dyspnea. Later, it developed GPS Capsule
that contains many functional ingredients besides GPS. This new product is
proved effective in treating the chronic obstructive pulmonary disease as an
immunotherapy in phase I and II clinical trials and now under III clinical
trials. as an immunotherapy. If this new drug is approved to be put on the
market, it will fill in the gap which has hitherto existed in the clinical
medication for COPD.
Star Lake Bioscience
forecasts a net loss in 2017
Star
Lake Bioscience forecasted on 30 January 2018 that it would have made losses in
2017. The net loss is predicted to be USD26.96 million.
Star
Lake Bioscience is mainly engaged in businesses of active pharmaceutical
ingredients, feed additives and food. Its leading products include valine,
lysine, threonine and proline, and these products are not only sold
domestically but exported to Europe, the USA, India and Southeast Asia. As
disclosed by Star Lake Bioscience, the net loss was mainly due to increased
environmental protection costs and increased production costs
Jiangxi Tianxin
suspends production starting February 2018
Jiangxi
Tianxin suspends production on 1 February 2018 for equipment overhauls and
maintenance. Production is scheduled to resume in mid-March 2018, lasting for
45 days.
Jiangxi
Tianxin is mainly engaged in the production of active pharmaceutical
ingredients, food and feed additives, and its major products are vitamin B1,
vitamin B6, folic acid, etc. It is actually a factory of Zhejiang Tianxin
Pharmaceutical Co., Ltd. constructed in Jiangxi Province. At present, Jiangxi
Tianxin has 3,000 t/a of vitamin B1 and 5,000 t/a of vitamin B6, accounting for
a 30%+ and 70%+ market share respectively in the world. It is also the domestic
biggest producer of vitamin B1 and B6.
Guilin Layn to set up
agribusiness for building whole industrial chain platform
On
17 January 2018, Guilin Layn announced that it would set up a wholly-owned
subsidiary – Layn Agricultural – with USD1.54 million of its self-owned funds.
Layn
Agricultural will be mainly engaged in the R&D, cultivation, purchase/sale
and plantation of seeds and sprouts of Luo Han Guo, stevia rebaudiana,
sweet tea and other plants., the provision of relevant training and technical
guidance services, the purchase, sale, packaging and storage of plant and
subsidiary agricultural products as well as the investment and product
development in agriculture and forestry. Its establishment is aimed at building
a whole industrial chain platform for Guilin Layn's plant extract business to
enhance the latter's ability to respond to raw material price fluctuations and
ensure an adequate supply of quality products to reduce Guilin Layn's
production costs and further improve its core competitiveness.
Fufeng and Evonik
enters strategic partnership for the production of L-threonine
Fufeng
and Evonik have entered into a cooperation agreement for the production of
L-threonine. Fufeng will toll manufacture the amino acid for Evonik using
Evonik's technology. This will help strengthen Fufeng's position as a leading
domestic manufacturer of threonine, and for the first time, Evonik is now able
to offer it worldwide with a lean asset footprint.
Evonik
has over 60 years of experience in the production of essential amino acids and
provides solutions for efficient and sustainable animal nutrition to customers
in over one hundred countries around the world. What's more, it has
world-leading technologies of producing amino acids with chemical and
fermentation methods.
Amino acid health food
producer Real Nutriceutical sells three subsidiaries
On
22 December 2017, Real Nutriceutical sold three of its affiliated
enterprises–Anhui Shuangke, Nanjing Ruinian, and Wuxi Real Pharmaceutical at a
price of USD2.27 million. These enterprises are engaged in the production and
selling of pharmaceuticals, and their total losses reached USD0.95 million and
USD0.31 million in 2015 and 2016 respectively.
Real
Nutriceutical is a large-scale group engaged in the production, sale and R&D
of pharmaceuticals, health food, health-care beverage and cosmetics. Notably,
one of its knock-out products, Real Nutri amino acid oral liquid, is a No. 1
brand in the field, taking an over 40% market share domestically.
Layn USA and Cargill
sign new supply agreement
On
22 December 2017, Guilin Layn announced that its wholly-owned subsidiary Layn
USA had signed a Food Ingredient Supply Agreement with Starches & Sweeteners
Business of Cargill, which meanwhile indicated that their long-term, exclusive
Outsourcing and Supply Agreement signed on 1 November 2011 had come to an end.
According to the new agreement, specific product variety and quantity will be
subject to the individual order sent by Cargill to Layn USA.
About CCM
CCM
is China’s leading market intelligence provider for the fields of agriculture,
chemicals, food and feed.
Join
the discussion on China’s food market by coming to our LinkedIn and Facebook
group.
Follow
us on Twitter: @CCM_Kcomber